Sacral Erector Spinae Plane Block in Pilonidal Sinus Surgery
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Sacral Erector Spinae Plane Block, Standard Postoperative Analgesia.
- Who it may be relevant to
- Registry conditions: Sacral Erector Spinae Plane Block, Pilonidal Sinus. Basic parameters: 18 years — 65 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Evaluation of the Efficacy of Ultrasound-Guided Sacral Erector Spinae Plane Block in Postoperative Analgesia Management in Patients Undergoing Pilonidal Sinus Surgery
Overview
This study aims to evaluate the efficacy of ultrasound-guided Sacral Erector Spinae Plane (ESP) block for postoperative analgesia management in patients undergoing pilonidal sinus surgery under general anesthesia
Detailed description
Severe pain after pilonidal sinus surgery is a significant problem that reduces patient comfort. In this randomized, prospective study, patients will be divided into two groups (Sacral ESPB group and control group) using a computer randomization method before the surgery. In the Sacral ESPB group, the block will be performed under ultrasound guidance using a 20 ml local anesthetic volume immediately after the surgical procedure and before extubation. The study will compare postoperative rescue analgesic requirement, opioid consumption, pain scores (NRS), and the incidence of side effects and complications
Interventions
- Procedure Sacral Erector Spinae Plane Block
Immediately after the surgical procedure and before extubation, ultrasound-guided (Vivid Q) Sacral ESPB will be applied to the patient in the prone position using a total volume of 20 ml. - Drug Standard Postoperative Analgesia
No block will be applied to this group. Both groups will receive intravenous 400 mg ibuprofen and 100 mg tramadol 20 minutes before the end of the surgery, and routine 1000 mg paracetamol every 8 hours postoperatively
Primary outcome measures
- Total postoperative rescue analgesic (opioid) consumption. [Time frame: At 24 hours postoperatively (Cumulative total over the 24-hour period)]
Secondary outcome measures (2)
- Postoperative pain scores evaluated by the Numeric Rating Scale (NRS) [Time frame: At 1, 3, 6, 12, 18, and 24 hours postoperatively.]
- Incidence of opioid-related side effects and block-related complications. [Time frame: During the 24-hour postoperative period.]
Eligibility criteria
Inclusion criteria
- Patients scheduled for elective pilonidal sinus surgery.
- ASA physical status I and II
Exclusion criteria
- Allergy or sensitivity to local anesthetics or opioid drugs.
- Infection at the block site.
- Alcohol or drug addiction.
- Use of anticoagulant agents.
- Patient refusal.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
Turkey (Türkiye) · 1 center
- Istanbul Medipol University — Istanbul
Identifiers
NCT: NCT07534488 · Medipol 374, 20.03.2025